Plain-English translation of NCT07426055 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
The PRO-BOOST-LC trial is testing whether giving prostate cancer patients a higher, more concentrated dose of radiation therapy — delivered through different methods — works better than standard radiation therapy alone. Researchers will compare three different boost methods (internal radiation implants that are temporary or permanent, or a single focused external beam) against standard radiation treatment to see which approach gives men the best chance of controlling their cancer long-term.
Research shows that prostate cancer responds well to higher doses of radiation, but doctors aren't sure which delivery method works best. This trial exists to compare these different approaches directly in a fair way, so doctors can recommend the most effective treatment for future patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to one of four treatment groups: standard radiation therapy alone, or radiation therapy combined with one of three different boost methods (temporary implants, permanent seed implants, or a single focused external beam). Your treatment will involve multiple visits for planning and imaging, followed by your assigned radiation therapy over several weeks. You'll have follow-up visits to check how well the treatment worked and monitor for any side effects, with long-term follow-up scheduled as part of the study.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Poland